Core Viewpoint - Sanai Health Group (01889.HK) is expected to report a loss attributable to shareholders of approximately RMB 11.5 million to RMB 14 million for the six months ending June 30, 2025, compared to a profit of approximately RMB 9.8 million in the same period of 2024 [1] Financial Performance - The anticipated shift from profit to loss is primarily due to the absence of a significant one-time non-recurring gain from the sale of a subsidiary, which amounted to approximately RMB 17.04 million in 2024 [1] - The company has also recorded an increase in distribution costs and administrative expenses of approximately RMB 4.6 million related to Beijing Hangyang Health Technology Co., Ltd. and its subsidiaries, which were not accounted for in the same period of 2024 [1]
三爱健康集团(01889.HK)盈警：预期中期拥有人应占亏损1150万元至1400万元